Meeting
2021 ASCO Annual Meeting
Impact of systemic therapy sequencing on overall survival for patients with advanced BRAF-mutated melanoma.
Authors
B. Adi Kartolo
Division of Medical Oncology, Queen’s University, Kingston, ON, Canada
B. Adi Kartolo , Jasna Deluce , Wilma M. Hopman , Linda Liu , Tara D. Baetz , D. Scott Ernst , John Gordon Lenehan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 9552)
DOI
10.1200/JCO.2021.39.15_suppl.9552
Abstract #
9552
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma.
First Author: Alina Pascale
Poster
2023 ASCO Annual Meeting
Association of ultra-sensitive ctDNA assay to identify actionable variants and response to immune checkpoint inhibitor (ICI) therapy in metastatic melanoma.
First Author: Christoffer Gebhardt
Poster
2023 ASCO Annual Meeting
Phase II clinical trial of camrelizumab combined with famitinib for advanced acral and mucosal melanoma.
First Author: Lili Mao
Poster
2022 ASCO Annual Meeting
Multicenter real-world data of adjuvant treatment and disease outcome of patients with melanoma with high-risk of recurrence.
First Author: Elisabeth Livingstone